FiGHTING F!T: An exercise program for adolescents and young adults during cancer treatment in Western Australia

Not Applicable

Completed

• Conditions: Cancer; Cancer - Any cancer; Physical Medicine / Rehabilitation - Other physical medicine / rehabilitation

• Registration Number: ACTRN12620000663954
• Lead Sponsor: The University of Western Australia

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-06-10
• Study Completion: 2021-05-12
• Last Update Posted: 18 October 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 43

Inclusion Criteria

Participants must be aged between 15 and 25 years of age
-Diagnosed with a primary haematological malignancy or solid tumour.
-Scheduled to commence or commenced systemic cancer treatment e.g. chemotherapy, radiation therapy or a combination of both within a +- 2 week period (participants who have undergone surgery will only be eligible for the trial if surgery is used in combination with chemotherapy or radiation).
-Medically stable (as determined by their treating medical practitioner) with written clearance from a doctor in their treating team to undertake a progressive exercise program.

Exclusion Criteria

-Cognitive impairment (determined by a medical practitioner)
-Patients who undergo surgery only
-<6 months life expectancy
-Absolute contraindications to exercise e.g. unstable angina, uncontrolled heart failure, acute systemic infection accompanied by fever.
-Insufficient English to participate in the exercise programme and exercise assessments, or to complete the questionnaire.
-Pregnant or lactating.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To determine whether a 10-week individualised exercise intervention is associated with a reduced decline in physical fitness (VO2 peak- as measured by a sub maximal ramp protocol cycle ergometer test ) when compared with controls in 15 – 25 year old patients undergoing treatment for cancer from diagnosis. [baseline- 10 weeks (primary timepoint)- 20 weeks. ]